|
| Status |
Public on Jan 11, 2011 |
| Title |
Heparins treated human breast cancer MCF-7 cell |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
To inquire the a possible mechanism for heparin treatment improved cancer survival, three type of heparins: one standard heparin (unfractionated heparin (UFH), and two of low molecular weight heparin (LMWH) Fragmin and Clexane were used to treat cell for 24 hours. Total RNA was used for cDNA Microarray assay.
|
| |
|
| Overall design |
Untreated cells were used as controls. Cell were treated by three type of heparins one standard heparin (unfractionated heparin (UFH), and two of low molecular weight heparin (LMWH) Fragmin and Clexane (40 IU/ml for each) were used to treat cell for 24 hours. Triplicate samples were prepared.
|
| |
|
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| Submission date |
Jan 10, 2011 |
| Last update date |
Jan 23, 2019 |
| Contact name |
Yunliang Chen Chen |
| E-mail(s) |
ychen@tri-london.ac.uk
|
| Phone |
0044 (0)207 351 8306
|
| Fax |
0044 (0)207 351 8324
|
| Organization name |
Thrombosis Research Institute
|
| Street address |
Manresa Road
|
| City |
London |
| ZIP/Postal code |
SW3 6LR |
| Country |
United Kingdom |
| |
|
| Platforms (1) |
| GPL6480 |
Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (Probe Name version) |
|
| Samples (12)
|
|
| Relations |
| BioProject |
PRJNA136661 |
Less...
More...